Cholera Vaccine Market Is Poised To Value Over USD 207 million By 2031 | CAGR 15.8%
The cholera vaccine market is expected to grow significantly in the next decade. The disease, caused by a bacterium called Vibrio cholerae, affects millions of people each year and can be fatal if not treated properly. Currently, two vaccines are available to protect against cholera, but only one is licensed for use in the United States. The number of cholera cases has been declining in recent years, but the disease remains a serious public health threat in many parts of the world. In 2015, there were an estimated 1.4 million cases and 28,000 deaths from cholera, according to the World…
- Date: November 16, 2022
- Author: Quintero
- Category: PharmiWeb